Press "Enter" to skip to content

US drug body FDA revokes Hydroxychloroquine status as emergency medicine to treat COVID-19

The U.S. Food and Drug Administration on Monday revoked the emergency use authorisation for malaria drug hydroxychloroquine (HCQ) as a treatment for COVID-19.  The FDA said it was no longer reasonable to believe that oral formulations of hydroxychloroquine and the related drug chloroquine may be effective in treating the respiratory illness caused by the novel coronavirus.

Leave your comments

%d bloggers like this: